Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know.

Seminars in thoracic and cardiovascular surgery - 1 Jan 2014

Eguchi Takashi, Kadota Kyuichi, Park Bernard J, Travis William D, Jones David R, Adusumilli Prasad S

Abstract excerpt

In 2011, a new histologic classification of lung adenocarcinomas was proposed from a joint working group of the International Association for the Study of Lung Cancer, American Thoracic Society, and European Respiratory Society, based on the recommendation of an international and multidisciplinary panel. This classification proposed a method of comprehensive histologic subtyping (lepidic, acinar, papillary,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Adenocarcinoma of Lung

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Biopsy

Share to Neoplasm Recurrence, Local

Share to Neoplasm Staging

Share to Pneumonectomy

Share to Staining and Labeling

Share to Terminology as Topic

Source

Open in PubMed Open full text

Identifiers

PMID: 25527015
DOI: 10.1053/j.semtcvs.2014.09.002
PMCID: PMC4272758

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know.PMID 25527015Read ↗

Clinical relevance of the new IASLC/ERS/ATS adenocarcinoma classification.Semantic proximity Read ↗

The correlation of the International Association for the Study of Lung Cancer (IASLC)/American Thoracic Society (ATS)/European Respiratory Society (ERS) classification with prognosis and EGFR mutation in lung adenocarcinoma.Semantic proximity Read ↗

Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients.Semantic proximity Read ↗

Association of IASLC/ATS/ERS Histologic Subtypes of Lung Adenocarcinoma With Epidermal Growth Factor Receptor Mutations in 320 Resected Cases.Semantic proximity Read ↗

The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations.Semantic proximity Read ↗

Clinical usefulness of the 3-tier classification according to the proportion of morphological patterns for patients with pathological stage I invasive lung adenocarcinoma.Semantic proximity Read ↗

Pulmonary adenocarcinoma: a renewed entity in 2011.Semantic proximity Read ↗

Evaluation of the new IASLC/ATS/ERS proposed classification of adenocarcinoma based on lepidic pattern in patients with pathological stage IA pulmonary adenocarcinoma.Semantic proximity Read ↗

Simplified Molecular Classification of Lung Adenocarcinomas Based on EGFR, KRAS, and TP53 MutationsSemantic proximity Read ↗

High-risk-pattern lung adenocarcinoma with epidermal growth factor receptor mutation is associated with distant metastasis risk and may benefit from adjuvant targeted therapy.Semantic proximity Read ↗

[The high-grade growth pattern of invasive lung adenocarcinoma: an update].Semantic proximity Read ↗

Correlation of Histologic Subtypes and Molecular Alterations in Pulmonary Adenocarcinoma: Therapeutic and Prognostic Implications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.